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ABSTRACT
Introduction There is limited evidence regarding 
the effectiveness of timely integration of short- term 
specialised palliative care services for older people in 
primary care. Using a Theory of Change approach, we 
developed such an intervention, the Frailty+ intervention. 
We present the protocol of a pilot randomised controlled 
trial (RCT) with a process evaluation that aims to assess 
the feasibility and preliminary effectiveness of the Frailty+ 
intervention.
Methods and analysis We will conduct a pilot RCT in 
Flanders, Belgium. Frail older people who are discharged 
to home from hospital will be identified and recruited. 
Seventy- six will be randomly assigned either to the control 
group (standard care) or the intervention group (Frailty+ 
intervention alongside standard care). Data will be 
collected from patients and family carers. At the core of the 
Frailty+ intervention is the provision of timely short- term 
specialised palliative care facilitated by a nurse from the 
specialised palliative home care service over a period of 
8 weeks. We will assess feasibility in terms of recruitment, 
randomisation, acceptability of the intervention, retention 
in the programme and data completion. The primary 
outcome for assessing preliminary effectiveness is 
a mean score across five key symptoms that are 
amenable to change (ie, breathlessness, pain, anxiety, 
constipation, fatigue), measured at baseline and 8 weeks 
post- baseline. The process evaluation will be conducted 
in the intervention group only, with measurements at 
8–11 weeks post- baseline to evaluate implementation, 
mechanisms of change and contextual factors.
Ethics and dissemination The study has been approved 
by the ethics committee of University Hospital Ghent. 
Results will be used to inform the design of a full- scale 
RCT and will be published in a peer- reviewed, open access 
journal.
Trial registration number ISRCTN39282347; Pre- results.
INTRODUCTION
A growing number of people worldwide are 
living into old age, yet the added years of life 
are not always spent in good health1; many 
experience long periods of illness and multi-
morbidity (ie, the simultaneous presence 
of multiple chronic conditions) or frailty. 
Different conceptualisations and operational 
definitions are used to define frailty, although 
many focus on the physical/medical domain 
of frailty. Some also include other domains 
such as the psychological and social.2–4 In 
this study, we use the definition of the British 
Geriatrics Society, defining frailty as ‘a distinc-
tive health state that is related to the ageing 
process in which multiple body systems grad-
ually lose their inbuilt reserves’.2 Frailty is a 
Strengths and limitations of this study
 ► The timely short- term specialised palliative care 
service intervention was developed and modelled 
through synthesising evidence from a systematic 
literature review with qualitative research, includ-
ing perspectives of older people, family carers and 
professional stakeholders (eg, formal care providers, 
researchers, policy- makers), integrated in a Theory 
of Change.
 ► Thorough piloting of the intervention will ensure 
feasibility and acceptability of the intervention, the 
randomised controlled trial design and procedures 
and will facilitate determining the required sample 
sizes for future full- scale evaluations.
 ► We will conduct an in- depth process evaluation that 
has a vital role in understanding the feasibility and 
acceptability of the intervention and in optimising its 
design and evaluation.
 ► We will include a diverse population of frail older 
people, including patients without cognitive capacity 
who are often under- represented in clinical studies.
 ► We translated measures for the primary and sec-
ondary outcomes that were not available in Dutch 
by using forward- backward procedures; however, a 
formal validation of these measures in Dutch does 
not exist.
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common condition in old age, and an estimated 26% in 
those aged 80 and over are frail.5 The increased suscep-
tibility of frail older people to adverse health outcomes 
paired with the cumulative effects of various chronic 
health problems results in prolonged, complex and fluc-
tuating needs and symptoms in the last years of life.6 7 As 
populations are ageing, the number of frail older people 
with such complex needs and symptoms is expected to rise 
considerably in the near future. Although these problems 
are known, evidence is lacking regarding which inter-
ventions are effective in addressing the resulting needs. 
Hence, there is an urgent need to develop and evaluate 
interventions that can improve care for frail older people 
towards the end of life.
Palliative care is suggested by the WHO as a way to 
address the problems associated with life- threatening 
illness by means of early identification, assessment and 
treatment of physical, psychosocial and spiritual prob-
lems.8 However, it has traditionally been limited to 
patients with cancer and is often started in the terminal 
phase. Over the past decade, the WHO, researchers and 
clinicians have made strong calls for it to be initiated early 
in the course of any serious or advanced illness, even 
alongside life- prolonging treatments, to improve quality 
of life.7–9 Nevertheless, research shows that access to palli-
ative care is lower for older than for middle- aged and 
younger people10 and is often initiated only shortly before 
death (eg, the median number of days ranged from 15 in 
Belgium to 30 in Italy in a four- country comparison11). 
Frail older people may benefit from timely initiation of 
palliative care, especially in the community setting, as the 
majority of older people prefer to live at home as long as 
possible.12
Two complementary palliative care service models have 
been advocated across patient populations: generalist 
palliative care from healthcare professionals who provide 
basic management of symptoms, and specialised palliative 
care from a multidisciplinary service or a clinician whose 
core activity is to support primary care professionals in 
caring for patients and family carers.13 14 In particular at 
times when palliative care needs become too complex to 
be handled by generalist providers alone, the involvement 
of specialised palliative care services is recommended.13 14 
The EAPC Atlas of Palliative Care showed that, although 
typology varies, similar services are established in most 
European countries.15
Building on an integration of generalist and special-
ised palliative care, a new model of short- term integrated 
palliative and supportive care for people with multiple 
sclerosis has demonstrated feasibility and beneficial 
outcomes.16 17 This model consisted of episodic involve-
ment of a specialised palliative care service integrated 
with existing primary care providers.16 17 It has also been 
proposed for older people with frailty or other progres-
sive conditions.18–21
This protocol concerns a pilot randomised controlled 
trial (RCT) with a process evaluation that aims to assess 
the feasibility, acceptability and preliminary effectiveness 
of a timely short- term specialised palliative care service 
intervention for frail older people and their family carers 
in primary care (henceforth named the Frailty+ interven-
tion). We will conduct a pilot RCT as there is currently 
insufficient evidence on the feasibility and acceptability 
of such an intervention and RCT design.
Additionally, we will seek to answer the same research 
questions in the specific population of frail older people 
with a cancer diagnosis. This subanalysis is part of a 
research project (with LP as PI) linked to this pilot RCT. 
While previous studies have shown that palliative care, 
including early palliative care, can improve key symptoms 
in people affected by cancer,16 22 23 they have not tested 
whether this also applies to the specific health problems 
and disease trajectory experienced by older people with 
cancer. The cancer trajectory in older people is consider-
ably different from that of younger patients. An estimated 
80% of people aged over 85 experience multimorbidity24; 
43% of cancer patients aged 70 or over are frail.25 More-
over, cancer and cancer treatment can worsen a number 
of geriatric syndromes (eg, bone loss, anaemia, depres-
sion, fatigue, insomnia).26 The cumulative effects of these 
conditions can lead to complex and unpredictably fluc-
tuating symptoms over the course of several years.7 It is, 
therefore, important to test whether a timely short- term 
specialised palliative care service can be beneficial in this 
patient group as well.
The specific objectives of the pilot RCT are:
1. To pilot the Frailty+ intervention and evaluate its im-
plementation, mechanisms of change and contextu-
al factors potentially affecting implementation and 
outcomes.
2. To test the feasibility of the methods and procedures 
of the RCT.
3. To evaluate the preliminary effectiveness of the Frailty+ 
intervention in frail older people, with and without 
cancer, and their family carers.
METHODS AND ANALYSES
In describing the study protocol, we followed the Stan-
dard Protocol Items of the Recommendations for Inter-
ventional Trials 2013 Checklist27 and the Consolidated 
Standards of Reporting Trials 2010 checklist.28
Study design
We will conduct a pilot RCT with two parallel groups 
(38:38 patients) and an embedded process evaluation. 
The intervention group will receive the Frailty+ inter-
vention in addition to standard care. The control group 
will receive standard care. Patients who consent will be 
randomly assigned to one of the study arms after baseline 
assessment. The assessments will be conducted at baseline 
and 8 weeks after the baseline measurement. Data will be 
collected from patients and their family carers.
Study setting
In Belgium, multidisciplinary and trained teams of health-
care professionals are the main providers of specialised 
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palliative care at home. Their main goal is to advise 
general practitioners (GPs), healthcare professionals, 
counsellors, informal carers and volunteers involved in 
the provision of palliative home care of a patient and to 
organise and coordinate the provision of palliative care 
at home between different care providers.29 The GP’s 
approval is required to initiate this service,29 usually 
consisting of nurses, a psychologist and a palliative care 
physician and covering a geographical region. The inter-
vention in this study will be conducted in Flanders, the 
Dutch- speaking region of Belgium, in cooperation with 
two specialised palliative home care services. Recruitment 
of patients will be done via three hospitals in Flanders, 
one of which is a university hospital.
Eligibility criteria
Patients will be recruited on discharge from a hospital 
admission. The inclusion and exclusion criteria for 
patients are provided in table 1. For the specific recruit-
ment of frail older people with cancer (as specified above), 
we will apply an additional criterion based on a previous 
study of early palliative care in oncology.30 Additionally, 
patients will be asked to indicate their most important 
family carer. The inclusion and exclusion criteria for 
family carers are provided in table 2.
Treatment arms
Standard care (control) group
Patients in the control group will receive standard care 
from primary care providers (eg, GP, district nurses) and 
any specialists. If a patient is referred to a specialised palli-
ative home care service as part of standard care within 
their follow- up period (8 weeks), we will exclude them 
from the study.
Intervention group
We have developed and modelled the Frailty+ inter-
vention, using a theory- based development approach 
(Theory of Change) integrated with the UK Medical 
Research Council (MRC) framework for developing and 
Table 1 Inclusion and exclusion criteria for patients
Inclusion criteria
All connected by ‘AND’
1. Aged 70 years or over.
2. Have a Clinical Frailty Scale (CFS) score45 between 5 and 7, that is, mild to severe frailty, as 
judged by the treating physician in the hospital.*
3. Have one or more unresolved or complex symptoms or problems, as judged by the treating 
physician in the hospital.†
4. Are in a hospital and referred to return to their home in the regions covered by the 
participating specialised palliative home care services.
5. Are able to speak and understand Dutch, and provide informed consent to participate in the 
study. If a person lacks capacity to consent the representative specified in the Belgian law for 
patient rights will be approached.39
6. Have a family carer who is eligible and willing to participate (see table 2) OR do not have a 
family carer corresponding to the inclusion criteria.
Inclusion criterium for frail 
older people with cancer
7. Have advanced- stage solid tumour or haematological malignancy.
Exclusion criteria
All connected by ‘OR’
1. Have had one or more palliative care consultations (ie, specialised palliative home care 
service and/or palliative care unit) in the 6 months prior to inclusion in the study.
2. Have taken/are taking part in another research study that evaluates a palliative care 
intervention.
3. Have urgent palliative care needs and/or are deteriorating rapidly (and should therefore be 
referred to specialised palliative care).
*The CFS is a scale based on activities of daily living which categorises frailty on a scale of 0–9, with higher scores indicating greater frailty.45
†Unresolved or complex symptoms or problems can include situations such as, but not limited to: complex needs of patient and/or family in 
the physical, psychological, social and/or spiritual domain; complex end- of- life issues such as being ‘tired of living’, highly conflicted decision 
making, consideration of palliative sedation, requests for assisted dying or euthanasia; difficulties with advance care planning; patient 
characteristics or complexity due to cumulation of multiple problems; pre- existing complexity, for example, long- standing difficulties with 
finances/housing or mental health needs; difficult interactions between the patient, family and healthcare professionals (eg, dissonance or 
conflicts, older patients who refuse care).13 46
Table 2 Inclusion and exclusion criteria for family carers
Inclusion criteria
All connected by ‘AND’
1. Person for whom the patient (or representative if patient does not have cognitive capacity) 
indicated that they are the most important family carer or representative.
2. Person lives with the patient or has in- person contact with him or her at least twice a week.
Exclusion criteria
All connected by ‘OR’
1. Person has taken or is taking part in another research study that evaluates a palliative care 
intervention.
2. Person does not speak or understand Dutch.
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evaluating complex interventions.31–34 As part of this, 
we integrated the evidence of a previously conducted 
systematic literature review of specialised palliative care 
services for older people in primary care20 with qualita-
tive research, including qualitative interviews and group 
discussions with older people and family carers, Theory 
of Change workshops with professional stakeholders 
(ie, bringing together key professional stakeholders to 
develop a Theory of Change map and to encourage stake-
holder buy- in31) and research group meetings.
The Frailty+ intervention will be provided alongside 
any standard care. The core component of the Frailty+ 
intervention consists of the provision of timely short- term 
specialised palliative care, facilitated by a nurse from the 
specialised palliative home care service over a period of 
8 weeks; care should be holistic and based on needs as 
well as capacities; it should be person- centred and family 
focused as well as goal- oriented and proactive; collabo-
ration and integration with other healthcare profes-
sionals is essential (see box 1 for more information on 
each component). Additional implementation compo-
nents are added to this to ensure optimal implementa-
tion. They include informing, engaging and training of 
professionals involved in primary and secondary care in 
the intervention region and identification and referral 
of frail older people with complex unresolved symptoms 
who have been hospitalised and are referred home, and 
of their family carers.
Timing of intervention
The first home visit will take place within five working days 
after discharge from the hospital. The additional visits 
and the multidisciplinary meetings will be planned by the 
nurses from the specialised palliative home care service 
with each patient and family individually. We foresee at 
least one and on average three to four home visits per 
patient and additional telephone calls, if needed, over 
a period of 8 weeks. An overview of the participant flow 
through the pilot RCT is displayed in figure 1.
Outcomes and data collection
Objective 1: pilot the Frailty+ intervention and evaluate its 
implementation, mechanisms of change and contextual factors 
affecting implementation and outcomes
To address objective 1, we will conduct a process evalua-
tion, guided by the MRC process evaluation framework,35 
to evaluate the following:
1. Components and activities that were delivered as part 
of the Frailty+ intervention, their ‘dose’ or ‘quantity’, 
and the adaptations that were made to the initial inter-
vention description.
2. Views of and experiences with the timely short- term 
specialised palliative care service intervention, accord-
ing to healthcare professionals (palliative home care 
services, GPs, geriatric liaison teams, geriatricians), pa-
tients and family carers.
3. Occurrence and type of unexpected or adverse effects, 
according to healthcare professionals (palliative home 
care services, GPs, geriatric liaison teams, geriatri-
cians), patients and family carers.
4. Which external factors, if any, influenced the imple-
mentation and outcomes of the Frailty+ intervention 
according to healthcare professionals (palliative home 
care services, GPs, geriatric liaison teams, geriatri-
cians), patients and family carers.
The process evaluation focuses on the intervention so 
will be carried out in the intervention group only. We will 
use a mixed- methods approach, integrating quantitative 
and qualitative data. The data will be collected by the 
researcher and the data manager prior to recruitment 
and eight to eleven weeks after baseline (ie, at T1). The 
quantitative data will be collected through registrations 
in standardised documents developed by the researchers 
and by the use of a structured data extraction form to 
scan electronic patient records. The qualitative data will 
be collected through semistructured qualitative inter-
views and focus groups. The interviews and focus groups 
will be audio recorded and transcribed verbatim by the 
researcher. An overview of the data that will be collected 
and the methods and timing of data collection is given in 
table 3.
Evaluation of care delivered in control group
In order to evaluate and explore care in the control group, 
the researchers will conduct telephone interviews with the 
GP 8 weeks after the baseline measurement (after postin-
tervention assessment) to obtain the following informa-
tion: which care providers delivered care and where (eg, 
home, hospital); number of visits or consultations (by GP 
and other healthcare professionals), topics discussed, if 
Box 1 Description of the core component of the Frailty+ 
intervention
Timely integration of short- term specialised palliative care ser-
vice: 1–4 home visits with, if needed, additional phone follow- up, over 
a period of 8 weeks.
Holistic needs- based and capacity- based care: identifying and man-
aging support needs in the four palliative care domains that is, physical, 
psychological, social and existential/spiritual and focusing on disabili-
ties as well as functioning and capacities (strengths and deficits).
Person- centred and family focused: viewing family as both care re-
cipients and care providers.
Goal- oriented and proactive care: focus on the patient’s individual 
health and care goals across several health, life and care domains; sup-
porting the patient in defining and meeting realistic or attainable goals 
and determining how well these goals are being met. This also includes 
the initiation of advance care planning conversations and drafting an 
emergency response plan and out- of- hours plan.
Collaborative and integrative working: focus on multiprofessional 
and multidisciplinary collaboration, coordination and continuity of care 
from the perspective of the patient and family. This includes the or-
ganisation of at least one multidisciplinary face- to- face meeting with 
healthcare professionals involved in the patient’s care and appointing 
a key health professional for the patient and family within the primary 
care team who coordinates care within the multidisciplinary team.
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any multidisciplinary meetings were organised (and if so, 
who attended and which topics were discussed).
Objective 2: to test the feasibility of the methods and procedures 
of the RCT
The feasibility of the RCT methods and procedures will 
be tested in the intervention and control group using a 
mixed- methods approach, integrating quantitative and 
qualitative data (see table 4 for detailed information). The 
data will be collected by the researcher, the data manager 
and the hospital staff involved in patient recruitment. 
The quantitative data will be collected through registra-
tions in standardised forms developed by the researchers. 
The qualitative data will be collected through semistruc-
tured qualitative interviews and focus groups.
Objective 3: to evaluate the preliminary effectiveness of the 
Frailty+ intervention in frail older people
The evaluation of preliminary effectiveness will be carried 
out by comparing the intervention and control groups 
(see table 5 for details). We will measure the primary 
and secondary outcomes using structured questionnaires 
(administered in interview format). The data will be 
collected by the researcher and data manager at T0 and 
T1 from patients and family carers at a place and time 
of their preference. Respondents will be interviewed 
separately (or together, if they prefer). The primary 
outcome is the mean score across five key symptoms that 
are amenable to change (ie, breathlessness, pain, anxiety, 
constipation, fatigue) as measured using the integrated 
Palliative care Outcome Scale (iPOS). The iPOS is a 
validated questionnaire with good psychometric proper-
ties.36 37
In addition, we will measure exploratory outcomes 
(ie, outcomes that are used to frame future research 
questions or explore new hypotheses38) using a mixed- 
methods approach, integrating quantitative and qualita-
tive data (see table 5). These data will be collected by the 
researcher and the data manager at T1 only. The quan-
titative data will be collected through structured phone 
interviews and the qualitative data through semistruc-
tured qualitative interviews and focus groups. The qual-
itative interviews and focus groups will be audiorecorded 
and transcribed verbatim by the researcher.
For all participating patients, we will register basic 
sociodemographic data (ie, gender, age, educational 
attainment, current or previous professions) and aspects 
of their social situation (ie, living situation, marital status, 
number of children, geographical proximity and contact 
frequency with family and friends). Age at baseline, 
gender and medical diagnosis data will be taken from the 
patient medical file by hospital staff, other sociodemo-
graphic data at the T0 interview. We will also collect basic 
sociodemographic data of the family carer (ie, gender, 
age, relation to the patient) during the interview at T0.
Figure 1 Flow chart of participant flow through pilot RCT. GP, general practitioner; RCT, randomised controlled trial.
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Pretesting of questionnaires
The questionnaires to assess the primary and secondary 
outcomes from patients and family carers will be translated 
from English into Dutch, where necessary, using forward- 
backward procedures and pretested with five patients and 
five family carers (or until data saturation is reached). 
Participants for pretesting will be identified according to 
inclusion and exclusion criteria as described in tables 1 and 
2 and will be recruited at one of the participating hospitals.
Capacity and proxy measurements
If a patient does not have the capacity to consent to 
participation (according to the clinical judgement of the 
treating physician, see recruitment section for evalua-
tion of cognitive capacity) at T0 and/or at T1, a proxy 
respondent will be identified following stipulations of 
Belgian law concerning representatives of people lacking 
cognitive capacity.39 The first choice is the patient’s legal 
representative; if none has been assigned, this will be the 
Table 4 Feasibility of the methods and procedures: operationalisations and data collection methods
Data collected Methods of data collection Timing of data 
collection/extraction
Recruitment procedure
1. Number of eligible patients and family carers 
approached.
2. Number and characteristics of eligible 
patients and family carers who were 
not approached and reasons for not 
approaching them.
3. Number of approached patients, family 
carers and GPs who provided informed 
consent.
4. Number and characteristics of patients and 
family carers who refused to participate and 
reasons for refusal (if stated).
5. Views of and experiences with the 
information letter and informed consent 
procedure of patients, family carers and 
GPs.
6. Views of and experiences with the inclusion 
criteria and their application, and the 
introduction of the study to patients and 
family carers of the geriatric liaison team and 
geriatricians.
1. and 2. Registration on standardised form 
developed by researchers and completed by the 
hospital staff involved in recruitment.
3. and 4. Registration by researchers in standardised 
document developed by the researchers.
5. Semistructured qualitative interviews with patients 
and family carers and semistructured qualitative 
telephone interviews with GPs.
6. Focus groups with geriatric liaison teams and 
geriatricians.
1–4. Throughout the 
study period
5. and 6. T1: 8 weeks
Randomisation procedure
1. Number of patients who gave informed 
consent and who started their randomly 
allocated treatment.
2. Views of and experiences with the 
randomisation procedure of patients, family 
carers and GPs.
1. Registration by researchers in standardised 
document developed by the researchers.
2. Semistructured qualitative interviews with patients 
and family carers and semistructured qualitative 
phone interviews with GPs.
1. Throughout the 
study period
2. T1: 8 weeks
Retention in the study
Number of patients, family carers and GPs 
who dropped out of the study and reasons for 
dropping out (if stated).
Registration by researcher in standardised document 
developed by the researchers.
Throughout the study 
period.
Data collection completion
1. Number of patients and family carers who 
completed baseline measurements.
2. Number of patients and family carers who 
completed follow- up assessment (T1) and 
reasons for not completing the baseline 
measurements or follow- up measurements 
(if stated).
3. Patients’ and family carers’ views of and 
experiences with the baseline measurement 
and the follow- up assessments.
1. and 2. Registration by researcher in standardised 
document developed by the researchers.
3. Semistructured qualitative interviews with patients 
and family carers.
1. and 2. Throughout 
the study period
3. T1: 8 weeks
GPs, general practitioners.
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person named in the will as executor.39 Only when there 
is no person named as executor, the representative is the 
spouse or any other beneficiary.39 For data collection with 
proxy respondents, a proxy version of the patient ques-
tionnaire will be used.
Sample size
The main objective of this pilot RCT is to assess feasibility 
and acceptability of the intervention, and of the RCT 
methods and procedures. As determining effectiveness is 
not the main objective, sample size calculations seem of 
less importance.40 41 Nevertheless, we have conducted a 
provisional sample size calculation to allow the reader to 
interpret our analysis of preliminary effectiveness of the 
Frailty+ intervention based on the only similar RCT avail-
able at time of development (follow- up periods and the 
patient population differ to some extent).42 The interven-
tion will be evaluated in two groups: frail older people and 
frail older people specifically with a cancer diagnosis. We 
aim to include 50 eligible patients, 25 in each study arm; 
it is estimated that this will allow us to detect differences 
of >1.6 on the Palliative Outcome Scale (for individual 
items) at α=0.05 and power 1-β=0.80.42 After the target 
sample has been reached, we will sample an additional 25 
frail older people who have a cancer diagnosis in order to 
achieve a sample of N=50 frail older people with cancer 
(based on the estimate that around half of those included 
will have a cancer diagnosis; clinical estimate based on 
patient numbers at the participating university hospital). 
The total sample will, therefore, be N=76 (rounded up to 
an even number). To allow for an expected attrition of 
45%, we plan to recruit at least 139 patients.
Recruitment
Patients will be recruited at the acute geriatric depart-
ment and through the geriatric liaison teams of several 
hospitals in Flanders. Each hospital will assign one staff 
member as contact person; the treating physician will 
judge if a patient meets the inclusion criteria and will ask 
them if they will agree to a researcher visiting them to 
Table 5 Primary and secondary outcomes and respective measures to pilot the RCT and assess preliminary effectiveness




Five key symptoms amenable to change in the 
past week (mean score across the items)
Integrated Palliative care 
Outcome Scale (iPOS)37
Patients 5 T0: 0 weeks
T1: 8 weeks
Secondary outcomes
Most distressing symptom in the past week Extra question added to the 
iPOS37
Patients 1 T0: 0 weeks
Palliative care needs iPOS37 Patients 17 T0: 0 weeks
T1: 8 weeksWell- being ICECAP Supportive Care 
Measure47
Patients 7
Sense of security in care Sense of Security in Care- 
Patients48
Patients 15
Continuity of care* Nijmegen Continuity of Care49 Patients 16
Views on care* Palliative care Outcome Scale - 
Views on Care50
Patients 1
Sense of security in care Sense of Security in Care–
Relatives51
Family carers 17
Family carers’ support needs Family Appraisal of Caregiving 




Healthcare utilisation (number and length of 
hospital admissions, including to intensive 
care unit and emergency department, number 
of GP visits and days spent in hospital or 
elsewhere).
Structured phone interviews. GPs n/a T1: 8 weeks
Patient’s and family carer’s perspective on the 




Patients and family carers
Attitudes towards and feelings of team 
collaboration among healthcare professionals.




2. Specialised palliative home 
care services, and separately 
with geriatric liaison teams 
and geriatricians.
*measured by subscales of the indicated questionnaire.
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introduce the study; if so, the treating physician or contact 
person will inform the research team. Once every 3 weeks, 
the researcher or data manager will attend the multidisci-
plinary meeting at the acute geriatric department in each 
hospital to ensure that all eligible patients are offered the 
opportunity to participate in the study.
On their initial visit, the researcher will inform the 
patient about the details of the study and what partici-
pation entails. They will explain the term ‘specialised 
palliative care service’ (ie, an additional service that is 
often provided at the end of life for people with advanced 
serious illnesses but may be beneficial also at earlier 
stages of illness), and that this study aims to test whether 
timely provision would be feasible and acceptable and 
beneficial for older people discharged from the hospital. 
If the patient agrees to participate, the researcher will 
ask them to provide written informed consent and indi-
cate their most important family carer (if they have one 
and conforming to inclusion and exclusion criteria) and 
whether they can be contacted for participation in the 
study. They will then visit the family carer to inform them 
about the study and obtain written informed consent. 
They will also ask the patient for permission to contact 
their GP to introduce the study and obtain their written 
informed consent to participate in the study.
If the patient does not have cognitive capacity 
(according to the clinical judgement of the treating physi-
cian) a proxy respondent will be approached (for details 
on this procedure, see outcomes and data collection 
section). It is important to test the Frailty+ intervention in 
those without cognitive capacity too as they form a large 
proportion of the older population43 ensuring that the 
conclusions apply to this population as well.
Patients randomised to the intervention group will be 
referred to the specialised palliative home care service by 
the researcher which will then obtain a formal referral 
from the GP, as required in the Belgian healthcare system. 
In case the patient is randomised to the control group, 
the GP will be informed and will provide standard care.
Patient recruitment started in January 2020 and is 
expected to end in December 2020 (last patient follow- up 
ends in February 2021). Due to COVID-19, recruitment 
was suspended between 13 March and 9 June 2020. We 
will adapt the timing should the crisis cause further delays.
Randomisation and blinding
Patients will be randomised in a 1:1 ratio to receive either 
the Frailty+ intervention or standard care. We will use a 
block randomisation technique with a variety in blocks, 
in order to reduce potential bias (ie, the variety in blocks 
prevents the researcher being able to predict which group 
the patient will be referred to) and achieve balance in 
allocation of patients to the intervention and control arm 
which will be done randomly by an external researcher 
independent of the research team for this study. This is an 
unmasked trial. The researchers involved in data collec-
tion cannot be blinded in this pilot RCT as the process 
evaluation is conducted in the intervention group only.
Analysis
Process evaluation and feasibility
The data collected via the standardised documents and 
the structured data extraction form developed by the 
researcher will be described using descriptive summary 
statistics (mean, SD, percentages). All qualitative data 
will be analysed by using thematic content analysis 
(ie, inductive coding into themes).44 One researcher 
will read the transcripts carefully several times to have 
a sense of the data, with a sample checked by another 
researcher. Both researchers will independently conduct 
the preliminary analysis by generating initial codes and 
converting them into categories that represent the main 
themes and categories arising from the data. The iden-
tified themes and categories will be compared, and in 
case of disagreement, a third reviewer will reconcile any 
discrepancies. Subsequently, meetings with the research 
team will enable consensus to be reached on the themes 
and categories. The analysis will be conducted in the 
original Dutch language, and final themes and cate-
gories (as well as selected quotes) will be translated to 
English by one researcher in cooperation with a profes-
sional translator.
Preliminary effectiveness
We will calculate summative scale scores for the primary 
and secondary outcomes. The resulting scale score for 
an individual is the sum of the individual item scores. If 
more than 25% of the items per scale were not answered 
(ie, missing), no sum score will be calculated for that scale 
and will be defined as missing. The pilot RCT data will 
be analysed on ‘intention- to- treat’ principle. This means 
that all patients who were enrolled and randomised will 
be accounted for in the main analysis, regardless whether 
they completed the Frailty+ intervention or not. The 
characteristics of patients in the intervention and control 
group will be described using descriptive summary 
statistics. We will test for differences in the primary and 
secondary outcomes between the groups at baseline and 
8 weeks later (ie, T1). Linear mixed- model analyses will 
be used with treatment, time and treatment- by- time inter-
action as independent variables and with two random 
factors, one for clustering of patients within hospitals and 
one for clustering of the two measures within patients. 
Linear mixed models handle missing data through 
maximum likelihood estimation, so no missing data 
imputation method will be applied. All significance tests 
will be two tailed and assessed at the 5% significance 
level. The quantitative exploratory data will be described 
using descriptive summary statistics and the qualitative 
data using thematic content analysis. All analyses will be 
conducted in IBM SPSS v25 and R.
Patient and public involvement
Patients and family carers were involved in the design of 
the study.









pen: first published as 10.1136/bm




10 de Nooijer K, et al. BMJ Open 2021;11:e043663. doi:10.1136/bmjopen-2020-043663
Open access 
ETHICS AND DISSEMINATION
Ethics approval and consent to participate
The study has been approved by the ethics committee of 
the University Hospital Ghent. In line with the General 
Data Protection Regulation (GDPR) guidelines of May 
2018, an internal register will provide all required infor-
mation on for example, the purposes of all processing 
operations; a description of the categories of data subjects 
and the recipients or categories of recipients to whom 
the data are disclosed; the legal basis of the processing 
operation for which the data are intended (the detailed 
internal register of all procession operations will also 
be sent to the Data Protection Officer of the University 
Hospital Ghent). In order to protect participants’ rights, 
information materials and informed consent forms are 
carefully formulated and structured to ensure that partici-
pants know exactly what participation in the study entails.
Distress protocol
The contact details of the researchers are mentioned on 
all information letters, consent forms and questionnaires. 
This allows the participants to contact the research team 
in case they feel the need to do so. In case a specific 
concern arises, the researcher will examine, together 
with the patient and family carer, which of their regular 
healthcare professionals is available to provide profes-
sional help and/or support. In addition, a psychologist 
from our research group (external to this project) will 
be available to provide support during the study period.
Confidentiality
The collected and transferred data will be pseudonymised 
to ensure that participants’ privacy and personal informa-
tion are protected (eg, all personal information that can 
lead to identification of the patient or the family carers is 
changed into a code by those that perform the data entry, 
eg, the researchers). We will use sufficient safety measures 
to protect the data, for example, virtual server firewall 
and back- up systems and sufficient access controls (ie, ID 
and ultrahigh password regulator and frequent password 
changes).
Availability of data and material
The final data set will be available to all researchers 
involved in this study. After reporting of the results, the 
data will be stored safely for 25 years, with Prof. Dr. Lieve 
Van den Block being responsible for their storage. The 
audio files will be deleted immediately after transcription. 
Following the publication of the main results of the pilot 
RCT, the respective data will be made available for non- 
commercial research purposes upon a reasonable request 
made to the researchers.
Dissemination
The results of this study (feasibility of the methods and 
evaluation of the intervention) will be submitted for publi-
cation in peer- reviewed journals and will be presented at 
national and international conferences. Participants and 
health care professionals involved in the study will be 
informed about the results in a leaflet. The results of this 
study will be used to adapt the theoretical model of the 
intervention and inform the design of a subsequent full- 
scale effectiveness trial.
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